Ardent Health, Inc. (NYSE:ARDT) Receives $19.33 Average PT from Analysts

Key Points

• Shares of Ardent Health, Inc. are rated as a "Moderate Buy" by eleven brokerage firms, with a current average 12-month price target of $19.3273.
• Recently, Wall Street Zen upgraded the company's rating from "buy" to "strong-buy," while Bank of America downgraded it from "neutral" to "underperform."
• Ardent Health reported an EPS of $0.52 for the last quarter, exceeding expectations, and has set a fiscal year 2025 guidance with an EPS target range of $1.730-2.01.

Ardent Health, Inc. (NYSE:ARDT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eleven research firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $19.3273.

Several equities analysts have recently commented on the company. KeyCorp decreased their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. JPMorgan Chase & Co. decreased their price objective on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. UBS Group began coverage on Ardent Health in a report on Wednesday, September 10th. They issued a "buy" rating and a $17.00 price objective on the stock. Finally, Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 9th.

Ardent Health Stock Down 3.7%

Shares of NYSE ARDT traded down $0.49 during trading hours on Tuesday, hitting $12.82. The company had a trading volume of 2,359,669 shares, compared to its average volume of 286,704. The stock has a market capitalization of $1.83 billion, a P/E ratio of 7.08, a price-to-earnings-growth ratio of 5.88 and a beta of 0.30. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health has a 1-year low of $10.10 and a 1-year high of $20.72. The firm's 50 day moving average is $12.21 and its 200-day moving average is $13.07.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%.The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, analysts expect that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health

Institutional investors and hedge funds have recently bought and sold shares of the company. Oliver Luxxe Assets LLC grew its position in shares of Ardent Health by 1.5% in the 2nd quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company's stock valued at $1,197,000 after buying an additional 1,319 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Ardent Health during the fourth quarter worth approximately $27,000. Geode Capital Management LLC boosted its stake in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company's stock valued at $3,918,000 after purchasing an additional 1,769 shares during the last quarter. Squarepoint Ops LLC boosted its stake in Ardent Health by 1.8% during the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock valued at $1,739,000 after purchasing an additional 1,798 shares during the last quarter. Finally, CWM LLC lifted its position in shares of Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock worth $30,000 after buying an additional 2,001 shares in the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.